Guest lecturer explores the emerging frontiers in ROP therapy and the evolving ethical, clinical, and technological considerations.
Mary Elizabeth Hartnett, MD
Advertisement
Michael F. Marmor Professor in Retinal Science and Diseases at Stanford University
Articles by Mary Elizabeth Hartnett, MD
Advertisement
Latest Updated Articles
FLORetina 2025: Mary Elizabeth Hartnett on ROP research and risk managementPublished: December 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
Navigating geographic atrophy from biomarkers to bilateral therapy
2
Eichenbaum Acorns: Mentorship, momentum, and the making of a retina podcast
3
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
4